Inhibition of bacterial adhesion by sub-inhibitory concentrations: Brodimoprim vs trimethoprim

P. C. Braga, G. Piatti, A. Limoli, M. Santoro, T. Gazzola

Research output: Contribution to journalArticle

Abstract

There is accumulating evidence that sub-inhibitory concentrations (sub-MICs) of many antibiotics are not without effect on bacteria and even though they do not kill bacteria, they are still able to interfere with some important aspects of bacterial cell function. The aim of the present study was to investigate the effect of sub-MICs of brodimoprim and trimethoprim on Escherichia coli and Staphylococcus aureus adhesiveness to human mucosal cells. Sub-MICs of brodimoprim down to 1/32 MIC (0.03 μg/ml) significantly reduced the E. coli adhesion to human buccal epithelial cells and this inhibition was significantly higher than the corresponding pattern for trimethoprim. Adhesion of S. aureus was significantly reduced down to 1/16 MIC for both brodimoprim and trimethoprim but no significant differences resulted between the two patterns. 2,4 Diaminopyrimidines and related structures have a high affinity for the enzyme dihydrofolate reductase and this causes a reduction in the synthesis of essential purines, thus reducing also DNA and the synthesis or expression of surface adhesins.

Original languageEnglish
Pages (from-to)447-452
Number of pages6
JournalJournal of Chemotherapy
Volume5
Issue number6
Publication statusPublished - 1993

Keywords

  • bacterial adhesivity
  • brodimoprim
  • E. coli
  • inhibition of adhesiveness
  • S. aureus
  • sub-MICs
  • trimethoprim

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Inhibition of bacterial adhesion by sub-inhibitory concentrations: Brodimoprim vs trimethoprim'. Together they form a unique fingerprint.

  • Cite this

    Braga, P. C., Piatti, G., Limoli, A., Santoro, M., & Gazzola, T. (1993). Inhibition of bacterial adhesion by sub-inhibitory concentrations: Brodimoprim vs trimethoprim. Journal of Chemotherapy, 5(6), 447-452.